What is she best known for?
The fields of study she is best known for:
- Gene
- Internal medicine
- Neuron
Michele Simonato mainly investigates Neuroscience, Epilepsy, Epileptogenesis, Neurotrophic factors and Hippocampal formation.
Michele Simonato combines subjects such as Internal medicine, Neurodegeneration and Endocrinology with her study of Neuroscience.
Her Epilepsy study integrates concerns from other disciplines, such as Disease, Bioinformatics and Intensive care medicine.
Her studies examine the connections between Epileptogenesis and genetics, as well as such issues in Brain-derived neurotrophic factor, with regards to Neurotrophin.
The study incorporates disciplines such as Neurogenesis and Exon in addition to Neurotrophic factors.
Her research integrates issues of Kainate receptor, Laser capture microdissection, Transcriptome and Pathology in her study of Hippocampal formation.
Her most cited work include:
- Identification of new epilepsy treatments: Issues in preclinical methodology (168 citations)
- Advances in the development of biomarkers for epilepsy (159 citations)
- Progress in gene therapy for neurological disorders (145 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Epilepsy, Neuroscience, Internal medicine, Endocrinology and Epileptogenesis.
The concepts of her Epilepsy study are interwoven with issues in Disease, Pharmacology, Bioinformatics and Intensive care medicine.
Michele Simonato interconnects Neurotrophic factors and Neurodegeneration in the investigation of issues within Neuroscience.
Her work on Glutamate receptor, Dentate gyrus, Acetylcholine and Receptor antagonist as part of general Internal medicine study is frequently linked to Nociceptin receptor, bridging the gap between disciplines.
Her Endocrinology research is multidisciplinary, relying on both Receptor and Kainate receptor.
Her Epileptogenesis research is multidisciplinary, incorporating perspectives in Biomarker, Pilocarpine, Clinical trial and microRNA.
She most often published in these fields:
- Epilepsy (50.87%)
- Neuroscience (49.13%)
- Internal medicine (29.48%)
What were the highlights of her more recent work (between 2017-2021)?
- Epilepsy (50.87%)
- Neuroscience (49.13%)
- Genetic enhancement (13.29%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Epilepsy, Neuroscience, Genetic enhancement, Cell biology and Bioinformatics.
Her work on Epileptogenesis and Status epilepticus as part of general Epilepsy research is frequently linked to Neurological disorder, bridging the gap between disciplines.
She works mostly in the field of Epileptogenesis, limiting it down to concerns involving Biomarker and, occasionally, Molecular biomarkers.
Her study brings together the fields of Neurotrophic factors and Neuroscience.
Her Genetic enhancement study also includes
- Gene silencing, Reporter gene, Regulation of gene expression and CRISPR most often made with reference to Transgene,
- Epilepsy therapy and related Oncology, Internal medicine, Focal Epilepsies and Vectors in gene therapy.
Her Bioinformatics research includes elements of Standard of care and Gene therapy for epilepsy.
Between 2017 and 2021, her most popular works were:
- Gene Therapy Tools for Brain Diseases. (35 citations)
- Gene Therapy Tools for Brain Diseases. (35 citations)
- Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy. (27 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Neuron
Her main research concerns Neuroscience, Epilepsy, Transgene, CRISPR and RNA interference.
Her Neurotrophic factors research extends to Neuroscience, which is thematically connected.
Her research in the fields of Seizure Disorders overlaps with other disciplines such as Genomics.
Her Transgene study incorporates themes from Reporter gene and Herpes simplex virus.
Her studies in CRISPR integrate themes in fields like Regulation of gene expression and Genetic enhancement.
Her microRNA research incorporates elements of Biomarker, Epileptogenesis and Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
